Results from an online poll completed by participants at the meeting show 64 percent of suppliers saw improved order-to-cash cycle management and procure-to-pay management as areas where UDIs could have the greatest impact, while 57 percent of providers saw adverse event reporting and recall management as potential areas of improvement, according to a news release.
The final UDI rule requires device manufacturers to assign a UDI-compliant code to each covered device as well as provide any additional information to a public, FDA-run database to improve the quality of devices and begin creating a global standardized protocol for identifying devices.
More Articles on Medical Devices:
Philadelphia Pediatric Device Consortium Receives $1.5M in FDA Funding
Report: Medical Instrument and Supply Manufacturing Industry Continues to Grow
GHX Offers Supply Chain Services to Improve Billing Accuracy
